Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Reason for the termination of treatment with the study drug.
| Reason for termination, n (%) | Group 1 (Darbepoetin alfa) | Group 2 (Epoetin alfa) |
|---|---|---|
| Achieved a Hb > 15 g/dL during RT or RCT | 20 (65.6%) | 20 (65.6%) |
| Hb 14 g/dL after RCT treatment | 23 (38.3%) | 17 (27.4%) |
| Completed 16 weeks of study drug | 4 (6.7%) | 1 (1.6%) |
| Study drug related or unrelated adverse event | 12 (19.7%) | 18 (29.0%) |
| Patient request | 4 (6.8%) | 7 (11.3%) |
2 patients in each group required RBC transfusions.
